High-dose melphalan-autologous hematopoietic cell transplantation in systemic AL amyloidosis following daratumumab-based frontline therapy
George Mellgard(Memorial Sloan Kettering Cancer Center), Rajshekhar Chakraborty(Columbia University Irving Medical Center), Matthew J. Maurer(Mayo Clinic in Arizona), Jai Radhakrishnan(Columbia University), Divaya Bhutani(Columbia University Irving Medical Center), Suzanne Lentzsch(Columbia University Irving Medical Center), Markus Y. Mapara(Sheba Medical Center)
Cited by 2
Related Papers
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2021|1.1k
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma
|Blood|2001|905
Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities
|Nature|2012|631
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders
|The Lancet Oncology|2019|493